ISSN: 1837-9664Journal of Cancer
Global reach, higher impact
J Cancer 2018; 9(10):1773-1781. doi:10.7150/jca.24577 This issue Cite
Review
Current status and future directions of cancer immunotherapy
Department of Respiratory Medicine, Yancheng Third People's Hospital, the Affiliated Yancheng Hospital of Southeast University Medical College, Yancheng, Jiangsu, China.
Citation:
Zhang H, Chen J. Current status and future directions of cancer immunotherapy. J Cancer 2018; 9(10):1773-1781. doi:10.7150/jca.24577. https://www.jcancer.org/v09p1773.htm
Other stylesAbstract
In the past decades, our knowledge about the relationship between cancer and the immune system has increased considerably. Recent years' success of cancer immunotherapy including monoclonal antibodies (mAbs), cancer vaccines, adoptive cancer therapy and the immune checkpoint therapy has revolutionized traditional cancer treatment. However, challenges still exist in this field. Personalized combination therapies via new techniques will be the next promising strategies for the future cancer treatment direction.
Keywords: cancer, immune system, cancer immunotherapy, challenges, future directions
Citation styles
APA
Zhang, H., Chen, J. (2018). Current status and future directions of cancer immunotherapy. Journal of Cancer, 9(10), 1773-1781. https://doi.org/10.7150/jca.24577.
ACS
Zhang, H.; Chen, J. Current status and future directions of cancer immunotherapy. J. Cancer 2018, 9 (10), 1773-1781. DOI: 10.7150/jca.24577.
NLM
Zhang H, Chen J. Current status and future directions of cancer immunotherapy. J Cancer 2018; 9(10):1773-1781. doi:10.7150/jca.24577. https://www.jcancer.org/v09p1773.htm
CSE
Zhang H, Chen J. 2018. Current status and future directions of cancer immunotherapy. J Cancer. 9(10):1773-1781.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.